1 minute read
Feb. 9, 2022
MK-0616: a Macrocyclic PCSK9 Inhibitor
Merck PCSK9 Inhibitors
macrocyclic PCSK9/LDLR PPI inhibitor oral PD in Ph. I with MK-0616 from mRNA display screen and SBDD published example: compound 44 Merck & Co.
Loading...
macrocyclic PCSK9/LDLR PPI inhibitor oral PD in Ph. I with MK-0616 from mRNA display screen and SBDD published example: compound 44 Merck & Co.